Cell adhesion molecules and incident hypertension in black and white adults: the REGARDS study

Tyler Harkness1, Katherine Wilkinson2, Ying K Loo3

  • 1Boston Medical Center, Boston, Massachusetts.

PubMed

Insights

Inflammation biomarkers E-selectin and ICAM-1 show links to new hypertension cases, particularly in White adults. Further research into modifying E-selectin could help prevent hypertension development.

Area of Science:

  • Cardiovascular Disease Epidemiology
  • Inflammation and Immunology
  • Hypertension Research

Background:

  • Inflammation, indicated by C-reactive protein, is linked to increased hypertension risk.
  • Cell adhesion molecules like E-selectin, ICAM-1, and VCAM-1 play roles in inflammation but their association with incident hypertension is not well-understood.

Purpose of the Study:

  • To investigate the association between baseline levels of E-selectin, ICAM-1, and VCAM-1 and the risk of developing incident hypertension.
  • To explore potential racial differences in these associations among US adults.

Main Methods:

  • The study utilized data from 1879 nonhypertensive participants (aged ≥45 years) from the REGARDS cohort, with a median follow-up of 9 years.
  • Modified Poisson regression was used to estimate the relative risk (RR) of incident hypertension across tertiles of baseline E-selectin, ICAM-1, and VCAM-1.
  • Participants with existing hypertension or missing biomarker data at baseline were excluded.

Main Results:

  • During follow-up, 36% of participants developed hypertension.
  • Higher E-selectin levels were associated with an increased risk of incident hypertension among White adults (RR 1.27; 95% CI 1.04-1.44 comparing tertile 3 vs. 1 in minimally adjusted models).
  • ICAM-1 showed an association with greater hypertension risk in unadjusted models, while VCAM-1 levels were higher in White participants.

Conclusions:

  • E-selectin showed an association with incident hypertension in White adults, and ICAM-1 showed associations in both White and Black adults in some models.
  • These findings suggest that E-selectin and ICAM-1 may be relevant biomarkers for hypertension risk.
  • Targeting E-selectin modification could be a potential strategy to reduce hypertension development.
Abstract

Related Concept Videos

Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
5.1K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886